Bayer to Present 13 Abstracts From Its Stroke Franchise at ESOC 2026, Including Two Late-breaking Analyses From the Phase III OCEANIC-STROKE Trial of Asundexian

Go back to Bayer to Present 13 Abstracts From Its Stroke Franchise at ESOC 2026, Including Two Late-breaking Analyses From the Phase III OCEANIC-STROKE Trial of Asundexian
Bay National Corporation (AMEX: BAYN) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $0.04 
Open $61.11    52 Week Low $0.03 
Day High $0.01    P/E 0.00 
Day Low $0.01    EPS $-8.34 
Volume 358,028       

Bay National Corporation (AMEX: BAYN) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $0.04 
Open $61.11    52 Week Low $0.03 
Day High $0.01    P/E 0.00 
Day Low $0.01    EPS $-8.34 
Volume 358,028       

Bayer Aktiengesellschaft American Depositary Shares (AMEX: BAYRY) Delayed: 10.81 +0.25 (2.37%)
Previous Close $10.56    52 Week High $135.54 
Open $10.66    52 Week Low $94.36 
Day High $10.90    P/E N/A 
Day Low $10.65    EPS $0.00 
Volume 651,428       

Bayer AG (AMEX: BAYZF) Delayed: 43.16 -1.15 (2.6%)
Previous Close $44.31    52 Week High $135.00 
Open $42.88    52 Week Low $94.95 
Day High $43.16    P/E N/A 
Day Low $42.88    EPS $0.00 
Volume 1,341